RichardMTroschMD

Neurology • Southfield, MI

Movement Disorder

Associate Professor, Internal Medicine, Oakland University Wm Beaumont SOM

Join to view full profile

Dr. Trosch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Trosch's full profile

Already have an account?

Office
26400 W 12 Mile Rd
Ste 110
Southfield, MI 48034
Phone+1 248-355-3875

Fax+1 248-355-3857

Education & Training

Columbia University College of Physicians and Surgeons1990 - 1991
Yale-New Haven Medical CenterChief Residency, Neurology, 1989 - 1990
Yale-New Haven Medical CenterResidency, Neurology, 1987 - 1989
Henry Ford Health/Henry Ford HospitalInternship, Internal Medicine, 1986 - 1987
Wayne State University School of MedicineClass of 1986
University of Michigan Honors CollegeBS, Psychology, 1978 - 1982

Certifications & Licensure

MI State Medical License 1991 - 2025
FL State Medical License 2012 - 2016
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
The Best Doctors in America 2008
Telly Award for a Medical Education Television Program 2004
Attending Physician of Year Sinai Hospital, Detroit, Michigan, 1991
House Officer Award for Intern Class Henry Ford Hospital, Detroit, MI, 1987
Join now to see all

Publications & Presentations

PubMed

21 citations
Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale.
Alberto J. Espay, Richard Trosch, Gustavo Suarez, Jonathan Johnson, Dominic Marchese
Parkinsonism & Related Disorders. 2018-07-01
7 citations
Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm: Results from an open-label, dose-escalation safety study†
Richard M. Trosch, Charles H. Adler, Eric J. Pappert
Movement Disorders. 2007-07-15
13 citations
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
M F Brin, M F Lew, C H Adler, C L Comella, S A Factor
Neurology. 1999-10-22

Journal Articles

Sodium nitoprusside and hypertension in neurologic illness.
Trosch RM, Raps EC, Fink ME, NEJM
The effects of aging on cerebral blood flow in patients with migraine equivalents.
Robertson WM, Ramadan NM, Levine SR, Schultz LR, Trosch RM, Welch KMA, Neurology
Localization of emotional facial paresis.
Trosch RM, Waxman SG, Brass LM, Neurology
Botulinum A toxin injections for the treatment of hand tremors.
Trosch RM, Pulman S, Ann Neurology
Botulinum A toxin treatment of hemimasticatory spasm in Parry Romberg syndrome.
Trosch Rm, Rontal M, Movement Disorders
Clozapine treatment of dystonia in Parkinson’s disease.
Trosch Rm, Friedman JH, LeWitt PA, Movement Disorders
Clozapine use in Parkinson’s disease.
Trosch RM, Neurology
Unexpected outcomes with tolcapone in Parkinson’s disease.
Trosch RM, LeWitt PA, Movement Disorders
Westphal variant of Huntington’s disease masquerading as MSA.
Trosch RM, LeWitt PA, Movement Disorders
An open-label trial of tolcapone in Parkinson’s disease.
Davis TL, Charles PD, Saint-Hilaire MH, Trosch RM, LeWitt PA, Kurth MC, Pedder S, Dorflinger E, Movement Disorders
Botulinium toxin type B decreases pain in patients with cervical dystonia.
Trosch RM, Pain Medicine
GNAL is a new causative gene for Primary Dystonia.
Fuchs T1, Saunders-Pullman R2,3, Masuho I4, San Luciano M5, Raymond D2, Factor S6, Lang AE7, Liang TW8, Trosch RM9, White S1, Ainehsazan E1, Herve D10, Sharma N11, Ehr..., Nature Genetics
Safety and efficacy of pramipexole in early Parkinson’s disease: A randomized dose-ranging study.
The Parkinson Study Group, JAMA
Pramipexole in Levodopa-treated Parkinson’s disease patients of africian, asian, and Hispanic heritage.
Parkinson Study Group, Clin Neuropharmacol
Join now to see all

Press Mentions

Physicians' Experience with RYTARY (Carbidopa and Levodopa) Extended-Release Capsules in Patients Who Have Parkinson DiseaseJune 24th, 2016
Physicians' Experience with RYTARY (Carbidopa and Levodopa) Extended-Release Capsules in Patients Who Have Parkinson DiseaseApril 4th, 2016